{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-120392","form_type":"8-K","ticker":"TWST","cik":"0001581280","company_name":"Twist Bioscience Corp","filed_at":"2022-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.270872+00:00","generated_at":"2026-06-21T15:50:48.490452+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Twist Bioscience amends bylaws to add proxy access for 3% long-term stockholders","bullets":["Proxy access provision allows stockholders/groups of up to 20 owning ≥3% for ≥3 years to nominate up to 2 or 20% of directors.","Deleted requirement for stockholder list examination at meetings to conform to recent Delaware law changes.","Added universal proxy rule requirements: nominating stockholders must confirm solicitation from ≥67% of voting power and provide evidence.","Other technical, conforming, and non-substantive changes included."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-120392","json":"https://secwatch.observer/filing/0001104659-22-120392.json","markdown":"https://secwatch.observer/filing/0001104659-22-120392.md","text":"https://secwatch.observer/filing/0001104659-22-120392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581280/000110465922120392/0001104659-22-120392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581280/000110465922120392/tm2230963d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T15:50:48.490452+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a597edfee25e4ab6903d6b164160ef4ea182fb6c","claim":"Twist Bioscience Corp: Approved amended and restated bylaws adding proxy access provision, eliminating stockholder list inspection requirement, and addressing universal proxy rules (effective 2022-11-17).","evidence_excerpt":"The Bylaws, as amended and restated (the “Restated Bylaws”), were effective immediately and include, among other things, the following changes: · adding a proxy access provision, inserted as new Section 2.13 of Article II of the Restated Bylaws, to allow a stockholder or a group of up to 20 stockholders owning at least 3% of the Company’s outstanding common stock continuously for at least three years to nominate and include in the Company’s proxy statement for an annual meeting director nominees constituting up to the greater of two individuals or 20% of the number of directors in office, provided that the stockholders satisfy the requirements specified in the Restated Bylaws; · eliminating the requirement that the list of stockholders be open to examination at meetings of stockholders to conform to recent amendments to the Delaware General Corporation Law; and · addressing matters relating to Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the “Universal Proxy Rules","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1581280/000110465922120392/0001104659-22-120392-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2022-11-17"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}